🇺🇸 FDA
Pipeline program

Autologous Room Temperature stored Platelet transfusion

2020-01

Phase 2 mab active

Quick answer

Autologous Room Temperature stored Platelet transfusion for Reversal of Platelet Aggregation Inhibitors is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Reversal of Platelet Aggregation Inhibitors
Phase
Phase 2
Modality
mab
Status
active

Clinical trials